Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers.

作者: Chonlaphat Sukasem , Chalirmporn Atasilp , Pichai Chansriwong , Montri Chamnanphon , Apichaya Puangpetch

DOI: 10.1002/JCLA.21820

关键词:

摘要: Background UGT1A1 is a polymorphic enzyme that has been associated with irinotecan drug metabolisms. We developed pyrosequencing method to detect allele frequency and genotype of UGT1A1 polymorphisms (UGT1A1*28 UGT1A1*6) in Thai colorectal cancer patients. Method A was designed determine genetic including UGT1A1*28 (A[TA]7TAA) UGT1A1*6 (211G>A) 91 cancers. Result Genotyping by the technique 100% concordant capillary electrophoresis sequencing. The frequencies for were *1/*1 (54.95%), *1/*6 (13.19%), *1/*28 (25.27%), *28/*6 (4.40%), *28/*28 (2.20%). No homozygous mutation found our population. Conclusions We rapid, reliable, more cost-effective, simple assay routine practice before initiating therapy. alleles be similar Asian populations.

参考文章(31)
Colin J. Davidson, Emily Zeringer, Kristen J. Champion, Marie-Pierre Gauthier, Fawn Wang, Jerry Boonyaratanakornkit, Julie R. Jones, Edgar Schreiber, Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection. BioTechniques. ,vol. 53, pp. 182- 188 ,(2012) , 10.2144/000113913
Chung-Pin Li, Sang-Hue Yen, Jiing-Chyuan Luo, Ying-Ying Wu, Chien-Hui Kao, Yee Chao, Sung-Hao Huang, Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer. Tumori. ,vol. 97, pp. 243- 247 ,(2011) , 10.1700/667.7793
Mark A. Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, Peter I. Mackenzie, Verawan Uchaipichat, Michael Stek, Joep M.A. Lange, Praphan Phanuphak, David A. Cooper, Wandee Udomuksorn, John O. Miners, Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir Pharmacogenetics and Genomics. ,vol. 16, pp. 321- 329 ,(2006) , 10.1097/01.FPC.0000197465.14340.D4
KOICHI HIROSE, CHIHIRO KOZU, KOSHIRO YAMASHITA, EIJI MARUO, MIZUHO KITAMURA, JUNICHI HASEGAWA, KEI OMODA, TERUO MURAKAMI, YORINOBU MAEDA, Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT1A1 gene Oncology Letters. ,vol. 3, pp. 694- 698 ,(2012) , 10.3892/OL.2011.533
Hironobu Minami, Kimie Sai, Mayumi Saeki, Yoshiro Saito, Shogo Ozawa, Kazuhiro Suzuki, Nahoko Kaniwa, Jun-ichi Sawada, Tetsuya Hamaguchi, Noboru Yamamoto, Kuniaki Shirao, Yasuhide Yamada, Hironobu Ohmatsu, Kaoru Kubota, Teruhiko Yoshida, Atsushi Ohtsu, Nagahiro Saijo, Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenetics and Genomics. ,vol. 17, pp. 497- 504 ,(2007) , 10.1097/FPC.0B013E328014341F
Ji-Youn Han, Hyeong-Seok Lim, Eun Soon Shin, Yeon-Kyeong Yoo, Yong Hoon Park, Jong-Eun Lee, In-Jin Jang, Dae Ho Lee, Jin Soo Lee, Comprehensive Analysis of UGT1A Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin Journal of Clinical Oncology. ,vol. 24, pp. 2237- 2244 ,(2006) , 10.1200/JCO.2005.03.0239
Eric Lévesque, Hugo Girard, Kim Journault, Johanie Lépine, Chantal Guillemette, Regulation of the UGT1A1 bilirubin‐conjugating pathway: Role of a new splicing event at the UGT1A locus Hepatology. ,vol. 45, pp. 128- 138 ,(2007) , 10.1002/HEP.21464
Zhe-Yi Hu, Qi Yu, Qi Pei, Cheng Guo, Dose-Dependent Association between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk Clinical Cancer Research. ,vol. 16, pp. 3832- 3842 ,(2010) , 10.1158/1078-0432.CCR-10-1122
Masashi Takano, Masafumi Kato, Tomoyuki Yoshikawa, Naoki Sasaki, Junko Hirata, Kenichi Furuya, Michiko Takahashi, Harushige Yokota, Nao Kino, Koji Horie, Tomoko Goto, Keiichi Fujiwara, Kenji Ishii, Yoshihiro Kikuchi, Tsunekazu Kita, Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers Oncology. ,vol. 76, pp. 315- 321 ,(2009) , 10.1159/000209335